Acetamide, 2-(methylthio)-N-[(2R,6S)-8-oxo-9,10-dioxa-1-borabicyclo[4.3.1]dec-4-en-2-yl]- manufacturers
- β-Lactamase-IN-8
-
- $2785.00
-
2026-04-21
- CAS:1929555-36-1
- Purity:
- Supply Ability: 10g
|
| | Acetamide, 2-(methylthio)-N-[(2R,6S)-8-oxo-9,10-dioxa-1-borabicyclo[4.3.1]dec-4-en-2-yl]- Basic information |
| | Acetamide, 2-(methylthio)-N-[(2R,6S)-8-oxo-9,10-dioxa-1-borabicyclo[4.3.1]dec-4-en-2-yl]- Chemical Properties |
| density | 1.26±0.1 g/cm3(Predicted) | | pka | 14.37±0.20(Predicted) |
| | Acetamide, 2-(methylthio)-N-[(2R,6S)-8-oxo-9,10-dioxa-1-borabicyclo[4.3.1]dec-4-en-2-yl]- Usage And Synthesis |
| Uses | β-Lactamase-IN-8 (compound 20) is a potent and oral bioavailable broad-spectrum cyclic boronate β-lactamase inhibitor. β-Lactamase-IN-8 can be used for researching antibacteria[1]. | | References | [1] Raja Reddy K, et al. Broad-spectrum cyclic boronate β-lactamase inhibitors featuring an intramolecular prodrug for oral bioavailability. Bioorg Med Chem. 2022;62:116722. DOI:10.1016/j.bmc.2022.116722 |
| | Acetamide, 2-(methylthio)-N-[(2R,6S)-8-oxo-9,10-dioxa-1-borabicyclo[4.3.1]dec-4-en-2-yl]- Preparation Products And Raw materials |
|